Diagnosis and Treatment of Barrett’s Oesophagus. A General Survey

References

• Iascone C., De Meester T. R., Little A. C., Skinner D. B. Barrett’s esophagus : Junctional assessment, proposed pathogenesis and surgical therapy. Arch Surg, 1983, 118 : 543-8
   PubMed Web of Science ®Google Scholar
• Bozymski E. M., Herlihy K. J., Orlando R. C. Barrett’s oesophagus. Ann Intern Med, 1982, 97 : 103-7.
   PubMed Web of Science ®Google Scholar
• Bozymski E. M., Shaheen J. N. Barrett’s oesophagus: Acid suppression, but no regression. Am J Gastroenterol, 1997, 92 : 556-8.
   PubMed Web of Science ®Google Scholar
• Cameron A. J., Lomboy C. T., Pera M., Carpenter H. A. Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology, 1995, 109 : 1541-6.
   PubMed Web of Science ®Google Scholar
• Blot W. J., Duvesa S. S., Kneller R. W., Freumeni J. F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA, 1991, 256 : 1287-9.
   Google Scholar
• Iascone C., Stipa S. Proper endoscopic surveillance of Barrett’s esophagus Acta Endosc, 1992, 22 : 507-12.
   Google Scholar
• Barrett N. R. Chronic peptic ulcer of the oesophagus and «-oesophagitis». Br J Surg, 1950,38: 175-82.
   PubMed Web of Science ®Google Scholar
• Spechler S. J., Goyal R. K. The columnar-lined esophagus, intestinal metaplasie, and Norman Barrett. Gastroenterology, 1996, 110: 614-21.
   PubMed Web of Science ®Google Scholar
• Mcclave S. A., Worth Boyce H. JR, Gottfriend M. R. Early diagnosis of columnar-lined esophagus : a new endoscopic diagnostic criterion. Gastrointest Endosc, 1987, 33 : 413-6.
   PubMed Web of Science ®Google Scholar
• Hameeteman W., Tytgat G. N. J., Houthoff H. J., Van Den Tweel J. G. Barrett’s esophagus : Development of dysplasia and adenocarcinoma. Gastroenterology., 1989, 96 : 1249-56.
   PubMed Web of Science ®Google Scholar
• Tytgat G. N. J. Does endocopic surveillance in esophageal columnar metaplasia (Barrett’s esophagus) have any real value? Endoscopy, 1995, 27 :, 19-26.
   PubMed Web of Science ®Google Scholar
• Clark G. W. B., Ireland A. P., De Meester T. R. Dysplasia in Barrett’s esophagus: diagnosis, surveillance and treatment. Dig Dis, 1996, 14 : 213-27.
   PubMed Web of Science ®Google Scholar
• Riddell R. H. The biopsy diagnosis of gastroesophageal reflux disease, ‘carditis’, and Barrett’s esophagus, and sequelea of therapy. Am J Surg Pathol, 1996 :S31-51.
   Google Scholar
• Weinster W. M., Ippoliti A. F. The diagnosis of Barrett’s esophagus : goblets, goblets, goblets. Gastrointest Endosc, 1996, 44 : 91-5.
   PubMed Web of Science ®Google Scholar
• Cameron A. J., Zinsmeister A. R., Ballard D. J., Carney J. A. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population based clinical and autopsy findings. Gastroenterology, 1990, 99 : 918-22.
   PubMed Web of Science ®Google Scholar
• Winters C. JR, Spurling T. J., Chobanian S. J., Curtis D. J., Esposito R. L., Hacker J. F. et al. Barrett’s esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology, 1987, 92 : 118-22.
   PubMed Web of Science ®Google Scholar
• Cameron A. J., On B. J., Payne W. S. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med, 1985, 313: 857-9.
   PubMed Web of Science ®Google Scholar
• Menke-Pluymers M. R., Hop W. C., Dees J., Van Blanken-Stein M., Tilanus H. W. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer, 1993, 72 : 1155-8.
   PubMed Web of Science ®Google Scholar
• Pera M., Cameron A. J., Trastek V. F., Carpenter H. Aa, Zinsmeister A. R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology, 1993, 104:510-3.
   PubMed Web of Science ®Google Scholar
• Blot W. J., Devesa S. S., Fraumeni J. F. Continuing climb in rates of esophageal adenocarcinoma : an update. JAMA, 1993, 270 : 1320.
   PubMed Web of Science ®Google Scholar
• Den Boogert J., Van Hillegersberg R., De Brulin R. W. F., Tilanus H. W., Siersema P. D. Barrett’s oesophagus: Pathophysiology, Diagnosis, and Managment. Scand J Gastroenterol, 1998, 33 : 449-53.
   PubMed Web of Science ®Google Scholar
• Clark G. W. B., Smyrk T. C., Burdiles P., Hoeft S. F., Peters J. H., Kiyabu M. et al. Is Barrett’s metaplasia the source of adenocarcinomas of the cardia? Arch Surg, 1994,129 : 609-14.
   PubMed Web of Science ®Google Scholar
• Wright T. A., Gray M. R., Morris A. I., Gilmore I. T., Ellis A., Smart H. L. et al. Cost effectiveness of detecting Barrett’s cancer. Gut, 1996, 39 : 574-9.
   PubMed Web of Science ®Google Scholar
• Spechler S. J., Goyal R. K. Barrett’s esophagus. N Engl J Med, 1986,315:362-71.
   PubMed Web of Science ®Google Scholar
• Monnier P., Fontolliet C., Savary M., Ollyo J. B. Barrett’s oesophagus or columnar epiyhelium of the lower oesophagus. Baillieres Clin Gastroenterol, 1987, 1 : 769-89.
   PubMed Web of Science ®Google Scholar
• Miwa K., Sahara H., Segawa M., Kinami S., Sato K., Miyazaki I. et al. Reflux of duodenal gstro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996, 6 : 269-74.
   Web of Science ®Google Scholar
• Attwood S. E. A., De Meester T. R., Bremmer C. G., Barlow A. P., Hinder R. A. Alkaline gastroesophageal reflux : implications in the development of complications in Barrett’s columnar-lined lower esophagus. Surgery, 1989, 106 : 764-70.
   PubMed Web of Science ®Google Scholar
• Vaezi M. F., Singh S., Richter J. E. Role of acid and duodenogastric reflux in esophageal mucosal injury : a review of animal and human studies. Gastroenterology, 1995, 108 : 1897-907.
   PubMed Web of Science ®Google Scholar
• Savarino V., Mela G. S., Zentilin P., Mele M. L., Mansi C., Remagnino A. C. et al. Time pattern of gastric acidity in Barrett’s esophagus. Dig Dis Sci, 1996, 41 : 1379-83.
   PubMed Web of Science ®Google Scholar
• Spechler S. J., Zeroogian J. M., Aantonioli D. A., Wang H. H., Gayal P. K. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet, 1994, 344 : 1533-6.
   PubMed Web of Science ®Google Scholar
• Geisinger K. R., Teot L. A., Richter J. E. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett’s esophagus. Cancer, 1991, 69: 8-16.
   Web of Science ®Google Scholar
• Haggitt R. C. Barrett’s esophagus, dysplasia and adenocarcinoma. Hum Pathol, 1994, 25 : 982-93.
   PubMed Web of Science ®Google Scholar
• Reid B. J., Haggitt R. C., Rubin C. E., Roth G., Surawicz C. M., Van Belle G. et al. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol, 1988, 19 : 166-78.
   PubMed Web of Science ®Google Scholar
• Menke-Pluymers M. B. E., Mulder A. H., Hop W. C., Van Blankenstein M., Tilanus H. W. Dysplasia and aneuploidy as markers of malignant degeneration in Barrett’s oesophagus. The Rotterdam Oesophageal Tumor Study Group. Gut, 1994, 35 : 148-51.
   Web of Science ®Google Scholar
• Krishnadath K. K., Tilanus H. W., Van Blankenstein M., Bosman F. T., Mulder A. H. Accumulation of p53 protein in normal dysplastic, and neoplastic Barrett’s oesophagus. J Pathol, 1995, 175 : 175-80.
   PubMed Web of Science ®Google Scholar
• Menke-Pluymers M. B. E. Risk factors for neoplastic progression in Barrett’s mucosa. Eur J Surg Oncol, 1996, 22 : 311-6
   PubMed Web of Science ®Google Scholar
• Streitz J. M., Andrews C. W., Ellis F. H. Endoscopic surveillance of Barrett’s oesophagus. Does it help?. J Thorac Cardiovasc Surg, 1993, 105 : 383-8.
   PubMed Web of Science ®Google Scholar
• Achkar E., Carey W. The cost of surveillance for adenocarcinoma complicating Barrett’s esophagus. Am J Gastroenterol, 1988, 83 : 291-4.
   PubMed Web of Science ®Google Scholar
• Provenziale D., Kemp J. A., Arora S., Wong J. B. A guide for surveillance of patients with Barrett’s esophagus. Am J Gastroenterol, 1994, 89 : 670-80.
   PubMed Web of Science ®Google Scholar
• Van Der Burgh A., Dees J., Hop W. C. J., Van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Gut, 1996, 39 : 5-8.
   PubMed Web of Science ®Google Scholar
• Spechler S. J., Robins A. H., Bloomfield R. H., Vincent M. E., Heeren T., Doos W. G. et al. Adenocarcinoma and Barrett’s esophagus : an overrated risk? Gastroenterology, 1984, 87 : 927-33.
   PubMed Web of Science ®Google Scholar
• Sampliner R. E., Garewall H. S., Fennetry M. B., Aickin M. Lack of impact of therapy on extent of Barrett’s oesophagus in 67 patients. Dig Dis Sci, 1990, 35 : 93-6.
   PubMed Web of Science ®Google Scholar
• Spechler S. J. Comparison of medical and surgical therapy for complicated gastroesophageal reflux in veterans. N Engl J Med, 1992, 326 : 786-92.
   PubMed Web of Science ®Google Scholar
• Sagar P. M., Ackroyd R., Hosie K. B., Patterson J. E., Stoddard C. J., Kingsnorth A. N. Regression and progression of Barrett’s oesophagus after antireflux surgery. Br J Surg, 7995, 82 : 806-10.
   Google Scholar
• Ortiz A., Martinez De Haro L. F., Parrilla P., Morales G., Molina J., Berjemo J. et al. Conservative treatment versus antireflux surgery in Barrett’s oesophagus : long-term results of a prospective study. Br J Surg, 1996,83 : 247-8.
   Google Scholar
• Levine D. S., Haggitt R. C., Blount P. L., Rabinovitch P. S., Rusch V. W., Reid B. J. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology, 1993, 105 : 40-50.
   PubMed Web of Science ®Google Scholar
• Cameron A. J., Carpenter H. A. Barrett’s oesophagus, high grade dysplasia and early adenocarcinoma. Comparison of endoscopic biopsy and surgical pathology findings. Gut, 1996, 38 suppl. 1 :T92.
   Google Scholar
• Fleischer De Wang G. Q., Dawsey S. M., Tio T. L., Kidwell J. A., Zhoe B. et al. Endoscopic therapy for esophageal dysplasia and early esophageal cancer in Linxian, China. Implications for the United States. Gastrointest Endosc, 1997, 45 : AB 68.
   Web of Science ®Google Scholar
• Berenson M. M., Johnson T. D., Markowitz N. R., Buchi K. N., Samowitz W. S. Restoration of squamous mucosa after ablation of Barrett’s esophageal epithelium. Gastroenterology, 1993, 104: 1686-91.
   PubMed Web of Science ®Google Scholar
• Sampliner R. E., Hixson L. J., Fennetry B., Garewall H. S. Regression of Barrett’s esophagus by laser ablation in an anacid environment. Dig Dis Sci, 1993, 38 : 365-8.
   PubMed Web of Science ®Google Scholar
• Sampliner R. E., Fennetry M. B., Garewall H. S. et al. Controlled trial of reversal of Barrett’s esophagus with acid suppression and multi-polar electrocoagulation (MPEC). Gastroenterology, 1995, 108 : A 208.
   PubMed Web of Science ®Google Scholar
• Van Hillegersberg R., Kort W. J., Wilson J. H. P. Current status of photodynamic therapy in oncology. Drugs, 1994, 48 : 510-27.
   PubMed Web of Science ®Google Scholar
• Overholt B. F., Panjehpour M. Barrett’s esophagus : photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc, 1995, 42 : 64-9.
   PubMed Web of Science ®Google Scholar
• Barr H., Shepherd N. A., Dix A., Roberts D. J. H., Tan W. C., Kranser N. Eradication of high-grade dysplasia of columnar-linedn (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet, 1996, 348 : 584-5.
   PubMed Web of Science ®Google Scholar
• Overholt B. F., Panjehpour M. Photodynamic therapy in Barrett’s esophagus: reduction of specialized mucosa, ablation of dysplasia and treatment of superficial esophageal cancer. Semin Surg Oncol, 1995,11 : 372-6.
   PubMedGoogle Scholar
• Laukka M. A., Wang K. K. Initial results using low-dose photodynamic therapy in the treatment of Barrett’s esophagus. Gastrointest Endosc, 1995, 42 : 59-63.
   PubMed Web of Science ®Google Scholar